2023: Harnessing the Power of Electrochemistry to Upgrade CO2 to Pharmaceuticals
Researchers intend to spearhead new technologies that efficiently harness CO2 as an abundant and sustainable carbon source product to generate valuable pharmaceutical building blocks, including amino acids and carboxylic acids. Researchers with expertise in electrochemical synthesis will collaborate with industrial partner Snapdragon, which specializes in continuous-flow production of pharmaceuticals, to translate their laboratory discoveries into industrial processes that can be immediately adopted by the chemical and pharmaceutical industries. If successful, this approach will not only offer a scalable solution to CO2 utilization but will also help improve the sustainability of pharmaceutical target production.
Investigator: Song Lin, Chemistry and Chemical Biology